Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice

Diabetes Research and Clinical Practice

Volumn 84, Issue 1, 2009, Pages 11-18

  Henry, Melissa ^a   Davidson, Lisa ^b,c   Cohen, Zoe ^c   McDonagh, Paul F ^c,d   Nolan, Paul E ^b   Ritter, Leslie S ^b,c  

^a UNIVERSITY OF NORTHERN COLORADO   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

C57BL 6J mice; CD61; Diet induced diabetes; Obesity; p selectin; Platelets; Type 2 diabetes

Indexed keywords

PADGEM PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; FLOW CYTOMETRY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD COAGULATION; DIABETES MELLITUS; DIETARY FATS; FLOW CYTOMETRY; INTEGRIN BETA3; MALE; MICE; MICE, INBRED C57BL; P-SELECTIN; PLATELET ACTIVATION; RANDOM ALLOCATION; THROMBELASTOGRAPHY;

EID: 62049086021     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.01.011     Document Type: Article

References (50)

1. Schneider D.J. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron. Artery Dis. 16 (2005) 473-476
2. Tan K.T., Yayebjee M.H., Lim H.S., and Lip G.Y.H. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet. Med. 22 (2005) 1657-1662
3. McDonagh P.F., Hokama J.Y., Gale S.C., Logan J.J., Davis-Gorman G., Goldman S., et al. Chronic expression of platelet adhesion proteins is associated with severe heart disease in type 2 diabetic patients. Chronic platelet activation in diabetic heart patients. J. Diabetes Complications 17 (2003) 269-278
4. Coban E., Ozdogan M., Yazicoiglu G., and Akcit F. The mean platelet volume in patients with obesity. Int. J. Clin. Pract. 59 (2005) 981-982
5. Koga H., Sugiyama S., Kugiyama K., Fukushima H., Watanabe K., Sakamoto T., et al. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur. Heart J. 27 (2006) 817-823
6. Diamant M., Nieuwland R., Pablo R.F., Sturk A., Smit J.W.A., and Radder J.K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106 (2002) 2442-2447
7. Corsonello A., Perticone F., Malara A., De Domenico D., Loddo S., Buemi M., et al. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 566-573
8. Ferreira I.A., Eybrechts K.L., Mocking A.I.M., Kroner C., and Akkerman J.W. IRS-1 mediates inhibition of Ca2++ mobilization by insulin via the inhibitory G-protein Gi. J. Biol. Chem. 297 (2004) 3254-3264
9. Westerbacka J., Yki-Jarvinen H., Turpeinen A., Rissanen A., Vehkavaara S., Syrjala M., et al. Inhibition of platelet-collagen interaction. An in vivo action of insulin abolished by insulin resistance in obesity. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 167-172
10. Dunn E.J., Philippou H., Ariens R.A.S., and Grant P.J. Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia 49 (2006) 1071-1080
11. Coppola G., Corrando E., Muratori L., Tantillo R., Vitale G., Lo Coco L., et al. Increased levels of c-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int. J. Cardiol. 106 (2006) 16-20
12. Coca M., Cucuianu M., and Hancu N. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen, and von Willebrand factor. Rom. J. Intern. Med. 43 (2005) 115-126
13. Erem C., Hacihasanoglu A., Celik S., Ovali E., Ersoz H.O., Ukinc K., et al. Coagulation and fibrinolysis parameters in type 2 diabetes patients with and without diabetic vascular complications. Med. Princ. Pract. 14 (2005) 22-30
14. Ludwig S., Dharmalingham S., Erickson-Nesmith S., Ren S., Zhu F., Ma G.M., et al. Impact of simvastatin on hemostatic and fibrinolytic regulators in type 2 diabetes mellitus. Diab. Res. Clin. Pract. 70 (2005) 110-118
15. Dubac P.U. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 25 (1976) 1567-1574
16. Wyse B.M., and Dulin W.E. The influence of age and dietary conditions on diabetes in the db mouse. Diabetologia 6 (1970) 268-273
17. Henry M.L.M., Davidson L.B., Wilson J.E., McKenna B.K., Scott S.A., McDonagh P.F., et al. Whole blood aggregation and coagulation in db/db and ob/ob mouse models of type 2 diabetes. Blood Coagul. Fibrinolysis 19 (2008) 125-134
18. Konstantinides S., Schafer K., Koschnick S., and Loskutoff D.J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest. 108 (2001) 1533-1540
19. Corsonello A., Malara A., De Domenico D., Perticone F., Valenti A., Buemi M., et al. Identifying pathways involved in leptin-dependent aggregation of human platelets. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 979-984
20. Elbatarny H.S., and Maurice D.H. Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E695-E702
21. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
22. Collins S., Martin T.L., Surwit R.S., and Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol. Behav. 81 (2004) 243-248
23. van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 99 (1997) 385-390
24. Surwit R.S., Petro A.E., Parekh P., and Collins S. Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice. Diabetes 46 (1997) 1516-1520
25. Mills E., Kuhn C.M., Feinglos M.N., and Surwit R.S. Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. Am. J. Physiol. 264 (1993) R73-R78
26. Schreyer S.A., Wilson D.L., and LeBoeuf R.C. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136 (1998) 17-24
27. Office of Laboratory Animal Welfare: Public Health Service Policy on Humane Care and Use of Laboratory Animals, Bethesda, MD, 2002 (NIH pub no. 80-23, revised 2002).
28. Goldenberg S.J., Veriabo N.J., and Soslau G. A micromethod to measure platelet aggregation and ATP release by impedance. Thromb. Res. 103 (2001) 57-61
29. Bowbrick V.A., Mikhailidis D.P., and Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets 14 (2003) 219-224
30. Salooja N., and Perry D.J. Thromboelastography. Blood Coagul. Fibrinolysis 12 (2001) 327-337
31. 3. Circulation 104 (2001) 1176-1180
32. Tsakiris D.A., Scudder L., Hodivala-Dilke K., Hynes R.O., and Coller B.S. Hemostasis in the mouse (Mus musculus): a review. Thromb. Haemost. 81 (1999) 177-188
33. Cohen Z., Gonzales R.F., Davis-Gorman G.F., Copeland J.G., and McDonagh P.F. Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb. Res. 107 (2002) 217-221
34. Chen Y., Davis-Gorman G., Watson R.R., and McDonagh P.F. Platelet CD62p expression and microparticle formation in murine acquired immune deficiency syndrome and chronic ethanol consumption. Alcohol Alcohol. 38 (2003) 25-30
35. Bonora E., Formentini G., Calcaterra F., Lombardi S., Marini F., Zenari L., et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Diabetes Care 25 (2002) 1135-1141
36. Libinaki R., Hefferman M., Jiang W.-J., Ogru E., Ignjatovic V., Gianello R., et al. Effects of genetic and diet-induced obesity on lipid metabolism. IUBMB Life 48 (1999) 109-113
37. Molnar J., Yu S., Mzhavia N., Pau C., Chereshnev I., and Dansky H.M. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ. Res. 96 (2005) 1178-1184
38. Thakker G.D., Frangogiannis N.G., Bujak M., Zymek P., Gaubatz J.W., Reddy A.K., et al. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am. J. Physiol. Heart. Circ. Physiol. 291 (2006) H2504-H2514
39. Hoover-Plow J., Shchurin A., Hart E., Sha J., Hill A.E., Singer J.B., et al. Genetic background determines response to hemostasis and thrombosis. BMC Blood Disord. 6 (2006) 1-12
40. Paigen B., Kovats S.E., Chapman M.H., and Lin C.Y. Characterization of a genetic difference in the platelet aggregation response of two inbred mouse strains, C57BL/6 and C3H/He. Atherosclerosis 64 (1987) 181-190
41. J.A. May, S. Heptinstall, Effects of anticoagulants used during blood cell collection on human platelet function, in: J.M. Gibbons, M.P. Mahaut-Smith (Eds.), Methods and Molecular Biology, vol. 272: Platelets and Megakaryocytes, vol. 1: Functional Assays, Humana Press, Inc., Totowa, NJ, 2004.
42. G.E. Jarvis, Platelet aggregation in whole blood, Impedance and particle counting methods, in: J.M. Gibbons, M.P. Mahaut-Smith (Eds.), Methods and Molecular Biology, vol. 272: Platelets and Megakaryocytes, vol. 1: Functional Assays, Humana Press, Inc., Totowa, NJ, 2004.
43. Vollmar B., Slotta J.E., Nickels R.M., Wenzel E., and Menger M.D. Comparative analysis of platelet isolation techniques for the in vivo study of the microcirculation. Microcirculation 10 (2003) 143-152
44. Walkowiak B., Kralisz U., Michalec L., Majewska E., Koziolkiewicz W., Liqocka A., et al. Comparison of platelet aggregability and p-selectin expression on platelets isolated by different methods. Thromb. Res. 99 (2000) 495-502
45. Paul W., Queen L.R., Page C.P., and Ferro A. Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat. British J. Pharm. 150 (2007) 105-111
46. Jurk K., and Kehrel B.E. Platelets: physiology and biochemistry. Semin. Thromb. Hemost. 31 (2005) 381-392
47. Sims P.J., Ginsberg M.H., Plow E.F., and Shattil S.J. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J. Biol. Chem. 266 (1991) 7345-7352
48. Celi A., Lorenzet R., Furie B.C., and Furie B. Microparticles and p-selectin-mediated pathway of blood coagulation. Dis. Markers 20 (2004) 347-352
49. van der Zee P.M., Biro E., Ko Y., de Winter R.J., Hack C.E., Sturk A., et al. P-selectin and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin. Chem. 54 (2006) 657-664
50. Tschoepe D., Menart B., Ferber P., Altmann C., Haude M., Haastert B., et al. Genetic variation of the platelet-surface integrin GPIIb/IIIa (PIA1/A2-SNP) shows a high association with type 2 diabetes mellitus. Diabetologia 46 (2003) 984-989